Scalp Cooling: How Does It Work and How Safe Is It?

Video

Hair loss is a common side effect in treatment for cancer, but for patients looking to manage it Dr. Julie Rani Nangia breaks down how scalp cooling can slow down hair loss.

Hair loss is just one of the many unwelcome side effects that patients with cancer may endure as a result of treatment with chemotherapy. But the use of cold caps — also known as scalp cooling – is a safe way to potentially reduce the amount of hair loss in some patients with solid tumors, according to Dr. Julie Rani Nangia of the Baylor College of Medicine.

In a recent interview with CURE, Nangia explained the science behind scalp cooling and went into greater detail about why the process is safe for patients with solid tumors like breast or ovarian cancer but should be avoided by those with blood cancers such as leukemia or lymphoma.

Transcription:

The way cold caps work — I'm going to kind of simplify it an easy way to understand – but there are kind of two main ways that they work. There are two big companies in the US: DigniCap and Paxman, and Paxman is the company that I worked with. But they're very similar and they basically have this mini refrigeration unit that attaches to a cold cap.

And these are different than the caps that you put in the freezer and put on that aren't attached to anything, because it circulates coolant and it keeps the cold temperature at a constant level on the scalp. And this is easier for both providers and patients because when you do scalp cooling, the fit is really important because if you have areas where there's not contact, you lose hair in those areas. So, you can just get a really good fit with a cap at the beginning of treatment and not have to keep putting it on and off. And then you have this constant temperature, you're not going from like really cold and drying out to warmer.

What this cold temperature does is two things: it constricts the blood vessels in the scalp and helps prevent chemotherapy delivery to the hair follicles, and then it also decreases the protein and enzyme activity in the hair follicles so the chemo that is delivered may not work as efficiently in the hair follicles. It's the combination of those two things.

And as far as safety goes, there's actually quite a few very large studies from other countries and US data also shows that these are safe to use. And what these studies have shown is that people who use scalp cooling devices or caps, that there's no difference in survival, so how long they live, and that there's no difference in having cancer recur in the scalp.

This is true for solid tumors. And by solid tumors, I mean cancers like breast cancer, lung cancer, ovarian cancer. But there are some cancers that spread through the bloodstream like leukemias and lymphomas, and in those types of cancers, these devices are not safe because you can protect cancer cells in the scalp and see local recurrences. So, I would not recommend using these for those types of tumors.

But these devices have been very well studied and they're FDA cleared for most solid tumors.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content